Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1312.5000 (0%) ($0.0000 - $0.0000) on Fri. Feb. 23, 2007. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 42.84% (three month average) | | RSI | 78 | | Latest Price | $1312.5000(0%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | CAPR declines -10.7% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
LQD(3%) TLT(3%) XLP(3%) EWI(2%) EWP(2%) | | Factors Impacting CAPR price | CAPR will decline at least -21.42% in a week (0% probabilities).
GLD(-0%) FXI(0%) XLU(1%) XLK(1%) VWO(1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -21.42% (StdDev 42.84%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| Resistance Level | $1329.92 | | 5 Day Moving Average | $1312.5(0%) | | 10 Day Moving Average | $1014.37(29.39%) | | 20 Day Moving Average | $1329.92(-1.31%) | | To recent high | -41.7% | | To recent low | 950% | | Market Cap | $25.853b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |